![Robert Clark](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 223 964 $ in data 30/06/2026
Robert Bruce Clark currently works at Incannex Healthcare, Inc., as Independent Non-Executive Director from 2023 and Novo Nordisk, Inc., as Vice President-US Regulatory Affairs from 2012.
Mr. Clark also formerly worked at Incannex Healthcare Pty Ltd., as Director from 2022 to 2023 and Pfizer Inc., as VP-Worldwide Regulatory Strategy from 1992 to 2021.
Mr. Clark received his graduate degree from New York Medical College.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 14/11/2025 | 59.565 ( 0,5% ) | 223 964 $ | 30/06/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| INCANNEX HEALTHCARE INC. | Direttore/Membro del Consiglio | 01/11/2023 |
Novo Nordisk, Inc.
 Novo Nordisk, Inc. BiotechnologyHealth Technology Develops biological medicines | Consigliere Generale | 01/01/2012 |
| Società | Posizione | Fine |
|---|---|---|
| PFIZER INC. | Corporate Officer/Principal | 01/01/2021 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 4 |
|---|---|
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Incannex Healthcare, Inc.
 Incannex Healthcare, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops cannabinoid and psychedelic compound medicines | Health Technology |
New York Medical College
 New York Medical College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novo Nordisk, Inc.
Novo Nordisk, Inc. BiotechnologyHealth Technology Develops biological medicines | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
